Clik here to view.
Medidata and Cogstate Strike Strategic Partnership Transforming Clinical...
NEW YORK Medidata, a Dassault Systèmes brand and the leading provider of clinical trial solutions to the life sciences industry, today announced a partnership with neuroscience solutions leader...
View ArticleClik here to view.
Organon完成对Dermavant的收购，包括其创新皮肤疗法VTAMA®（苯烯莫德）1%乳膏
新泽西州泽西市 (美国商业资讯)– 以改善女性终生健康为使命的全球医疗保健公司Organon (NYSE: OGN) 今天宣布成功完成对Roivant (NASDAQ: ROIV) 旗下Dermavant Sciences Ltd.的收购。Dermavant是一家专注于开发和商业化免疫皮肤病创新治疗解决方案的公司。如需了解交易条款概要，请参阅我们之前发布的公告。...
View ArticleClik here to view.
Clik here to view.
パース・バイオサイセンシズ、GigaLabを立ち上げ、シングルセル シーケンシングを年間数十億個に拡大
シアトル （ビジネスワイヤ） — アクセスしやすくスケーラブルなシングルセル シーケンシング ソリューションの大手プロバイダーであるパース・バイオサイエンシズは、シングルセル シーケンシングを年間数十億個の細胞に拡張するParse GigaLab™の立ち上げを発表しました。GigaLabは、スケールアップされたワークフローと拡張自動化機能を備えたパースのEvercode™シングルセル...
View ArticleClik here to view.
Parse推出GigaLab，将单细胞测序能力扩大到每年数十亿个细胞
西雅图 (美国商业资讯)– 易于获取的可扩展单细胞测序解决方案的领先提供商Parse Biosciences今天宣布推出Parse GigaLab™，将单细胞测序能力扩展到每年数十亿个细胞。GigaLab利用Parse的Evercode™单细胞技术，通过扩大工作流程和提高自动化程度，实现了被认为在现有单细胞方法下无法获取的发现。...
View ArticleClik here to view.
SCIEX to Localize the 6500+ systems in China, starting this December 2024
FRAMINGHAM, Mass. SCIEX, a global leader in life science analytical technologies, announces the localization of the SCIEX Triple Quad 6500+ system and the QTRAP 6500+ system in China. This...
View ArticleClik here to view.
PopVax Announces 1.15 Million USD in Funding from the Bill ＆ Melinda Gates...
MUMBAI, India & HYDERABAD, India PopVax, an Indian full-stack biotechnology company developing novel mRNA vaccines and therapeutics using computational protein design, is pleased to announce...
View ArticleClik here to view.
US FDA Accepts Biologics License Application (BLA) for HLX14, Biosimilar...
SHANGHAI, China & JERSEY CITY, N.J. Shanghai Henlius Biotech, Inc. (2696.HK) and Organon (NYSE: OGN) announced that the US Food and Drug Administration (FDA) has accepted the Biologic License...
View ArticleClik here to view.
bioAffinity Technologies Announces Award of Japanese Patent for CyPath® Lung
SAN ANTONIO bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive tests for the detection of early-stage lung cancer and other lung...
View ArticleClik here to view.
Three Phase 3 Trials of Datopotamab Deruxtecan-Based Combinations Initiated...
TOKYO & BASKING RIDGE, N.J. The first patients have been dosed in three global, randomized phase 3 trials evaluating the efficacy and safety of datopotamab deruxtecan (Dato-DXd)-based...
View Article